Overview

The Effect of Oral Isosorbide Mononitrate Therapy on Umbilical Artery Doppler Resistance Index in Pregnancies With Intrauterine Growth Restriction: Prospective Randomized Control Trial

Status:
Completed

Trial end date:
2022-12-06

Target enrollment:

Participant gender:

Summary

Will follow up umblical artery Doppler indices for pregnancies with iugr taking placebo and oral isosorbide mononitrate to study its efficacy on the intrauterine growth restricted fetuses

Phase:

Phase 4

Details

Lead Sponsor:

Ain Shams University

Treatments:

Isosorbide